Kidney cancer
A study of Platinum and Etoposide Chemotherapy after Surgery in Patients with High-Risk Adrenocortical Cancer
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 2: does it work?
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Advanced Centre for Treatment, Research and Education in CancerNavi MumbaiDirections ↗
Registry summary (technical)
A Phase II Study of Adjuvant Platinum-Etoposide in Patients with Resected High-Risk Adrenocortical Carcinoma - NIL
Sponsor: ACTREC, TMC
CTRI/2026/08/115858 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026